New polymeric biomaterials-phospholipid polymers with a biocompatible surface

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Biomedical Engineering

Background:

• Biocompatibility is crucial for implantable medical devices.
• Existing materials often face challenges with protein adsorption and blood cell adhesion.
• Biomimetic surfaces can improve device integration and longevity.

Purpose of the Study:

• To design and synthesize novel biomedical polymers with biomimetic membrane surfaces.
• To evaluate the protein adsorption and blood cell adhesion resistance of these polymers.
• To assess the efficacy of these polymers in improving the biocompatibility and biostability of implantable glucose sensors.

Main Methods:

• Synthesis of 2-methacryloyloxyethyl phosphorylcholine (MPC) copolymers with hydrophobic alkyl groups.
• Characterization of polymer surface properties, including phospholipid interaction and self-assembly.
• In vitro assessment of protein adsorption and blood cell adhesion.
• In vivo testing of MPC polymer-coated glucose sensors implanted subcutaneously in rats for 14 days.

Main Results:

• The MPC polymer surface successfully formed a self-assembled biomimetic membrane with concentrated, organized phospholipids.
• The MPC polymer exhibited excellent resistance to protein adsorption and blood cell adhesion, demonstrating good blood compatibility.
• MPC polymer-coated glucose sensors maintained stable output current levels for 14 days post-implantation.
• The MPC polymer significantly improved the biocompatibility and biostability of the implantable glucose sensor.

Conclusions:

• MPC polymers can create effective biomimetic membrane surfaces by interacting with phospholipids.
• These surfaces provide superior resistance to biofouling, leading to enhanced blood compatibility.
• MPC polymer coatings are highly promising for improving the performance and longevity of implantable biomedical devices, particularly sensors.